Quick Answer
IDEAYA Biosciences, Inc. reported Net Income Loss of -$113.70 million for the year ending 2025.
- IDEAYA Biosciences, Inc. showed an increase of +58.6% in Net Income Loss from 2024 to 2025.
- This data is from IDEAYA Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on February 17, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2017 to 2025), IDEAYA Biosciences, Inc.'s Net Income Loss has declined by 858.5%.
- Historical annual values: Fiscal year 2025: -$113.70 million | Fiscal year 2024: -$274.48 million | Fiscal year 2023: -$112.96 million | Fiscal year 2022: -$58.66 million | Fiscal year 2021: -$49.76 million | Fiscal year 2020: -$34.50 million | Fiscal year 2019: -$41.98 million | Fiscal year 2018: -$34.35 million | Fiscal year 2017: -$11.86 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: